UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide

Carbohydrate polymers, 2021-11, Vol.271, p.118417-118417, Article 118417

2021

Volltextzugriff (PDF)

A UL47 Gene Deletion Mutant of Bovine Herpesvirus Type 1 Exhibits Impaired Growth in Cell Culture and Lack of Virulence in Cattle

Journal of Virology, 2010-01, Vol.84 (1), p.445-458

2010

Volltextzugriff (PDF)

Cellulose-based polyelectrolyte complex nanoparticles for DNA vaccine delivery

Biomaterials science, 2014-01, Vol.2 (10), p.1440-1449

2014

Volltextzugriff (PDF)

Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction

International journal of biological macromolecules, 2020-09, Vol.159, p.46-56

2020

Volltextzugriff (PDF)

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA

Vaccine, 2007-02, Vol.25 (10), p.1701-1711

2007

Volltextzugriff (PDF)

Corrigendum to “Interaction of VP8 with mRNAs of bovine herpesvirus-1” [Virus Res. 197 (2015) 116–126]

Virus research, 2015-12, Vol.210, p.356-356

2015

Volltextzugriff (PDF)

Animal models for neonatal diseases in humans: Human Immune Response to Vaccines in the First Year of Life

Vaccine, 2013, Vol.31 (21), p.2489-2499

2013

Volltextzugriff (PDF)

Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection

Journal of general virology, 2008-01, Vol.89 (1), p.250-260

2008

Volltextzugriff (PDF)

Intracellular trafficking of VP22 in bovine herpesvirus-1 infected cells

Virology (New York, N.Y.), 2010, Vol.396 (20), p.189-202

2010

Volltextzugriff (PDF)

Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides: CpG Oligonucleotides as Immunotherapeutic Adjuvants: Innovative Applications and Delivery Strategies

Advanced drug delivery reviews, 2009, Vol.61 (3), p.226-232

2009

Volltextzugriff (PDF)

Characterization of nuclear localization and export signals of the major tegument protein VP8 of bovine herpesvirus-1

Virology (New York, N.Y.), 2004-07, Vol.324 (2), p.327-339

2004

Volltextzugriff (PDF)

A Distinct Role of CD4^sup +^ Th17- and Th17-Stimulated CD8^sup +^ CTL in the Pathogenesis of Type 1 Diabetes and Experimental Autoimmune Encephalomyelitis

Journal of clinical immunology, 2011-10, Vol.31 (5), p.811

2011

Volltextzugriff (PDF)

A U L 47 Gene Deletion Mutant of Bovine Herpesvirus Type 1 Exhibits Impaired Growth in Cell Culture and Lack of Virulence in Cattle

Journal of virology, 2010-01, Vol.84 (1), p.445-458

2010

Volltextzugriff (PDF)

Delivery of DNA vaccines using electroporation

Methods in molecular medicine, 2006, Vol.127, p.73

2006

Volltextzugriff (PDF)

Novel methods for the non-invasive administration of DNA therapeutics and vaccines

Current drug delivery, 2006-01, Vol.3 (1), p.3-15

2006

Volltextzugriff (PDF)

Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB

Journal of Virology, 1995-08, Vol.69 (8), p.4758-4768

1995

Volltextzugriff (PDF)

Strategies for improved formulation and delivery of DNA vaccines to veterinary target species: DNA vaccines & adjuvants

Immunological reviews, 2004, Vol.199, p.113-125

2004

Volltextzugriff (PDF)

Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D: DNA Vaccines

Vaccine, 2006, Vol.24 (21), p.4625-4629

2006

Volltextzugriff (PDF)

Needle-free delivery of veterinary DNA vaccines

Methods in molecular medicine, 2006, Vol.127, p.91

2006

Volltextzugriff (PDF)

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from theMycobacterium bovisantigen Rv3019c

Vaccine, 2005-08, Vol.23 (35), p.4375

2005

Volltextzugriff (PDF)

Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses☆☆This article is published as VIDO Journal Series 331

Virology (New York, N.Y.), 2003-08, Vol.313 (1), p.296-307

2003

Volltextzugriff (PDF)

Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV

Journal of Virology, 1991-03, Vol.65 (3), p.1124-1132

1991

Volltextzugriff (PDF)

The biology and development of vaccines for bovine herpesvirus 1

The veterinary journal (1997), 2024-05, p.106152

2024

Volltextzugriff (PDF)

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals: Veterinary Drug Delivery Part III

Advanced drug delivery reviews, 2000, Vol.43 (1), p.13-28

2000

Volltextzugriff (PDF)

Protection of turkeys against haemorrhagic enteritis by monoclonal antibody and hexon immunization

Vaccine, 1993, Vol.11 (3), p.329-335

1993

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide

A UL47 Gene Deletion Mutant of Bovine Herpesvirus Type 1 Exhibits Impaired Growth in Cell Culture and Lack of Virulence in Cattle

Cellulose-based polyelectrolyte complex nanoparticles for DNA vaccine delivery

Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA

Corrigendum to “Interaction of VP8 with mRNAs of bovine herpesvirus-1” [Virus Res. 197 (2015) 116–126]

Animal models for neonatal diseases in humans: Human Immune Response to Vaccines in the First Year of Life

Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection

Intracellular trafficking of VP22 in bovine herpesvirus-1 infected cells

Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides: CpG Oligonucleotides as Immunotherapeutic Adjuvants: Innovative Applications and Delivery Strategies

Characterization of nuclear localization and export signals of the major tegument protein VP8 of bovine herpesvirus-1

A Distinct Role of CD4^sup +^ Th17- and Th17-Stimulated CD8^sup +^ CTL in the Pathogenesis of Type 1 Diabetes and Experimental Autoimmune Encephalomyelitis

A U L 47 Gene Deletion Mutant of Bovine Herpesvirus Type 1 Exhibits Impaired Growth in Cell Culture and Lack of Virulence in Cattle

Delivery of DNA vaccines using electroporation

Novel methods for the non-invasive administration of DNA therapeutics and vaccines

Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB

Strategies for improved formulation and delivery of DNA vaccines to veterinary target species: DNA vaccines & adjuvants

Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D: DNA Vaccines

Needle-free delivery of veterinary DNA vaccines

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from theMycobacterium bovisantigen Rv3019c

Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses☆☆This article is published as VIDO Journal Series 331

Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV

The biology and development of vaccines for bovine herpesvirus 1

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals: Veterinary Drug Delivery Part III

Protection of turkeys against haemorrhagic enteritis by monoclonal antibody and hexon immunization

Aktive Filter

Suchergebnisse filtern